INN |
strength |
dosage form |
supplier |
site |
packaging |
abacavir |
300 mg |
tablet |
GlaxoSmithKline |
UK |
blister |
abacavir |
20 mg/ml |
oral solution |
GlaxoSmithKline |
UK |
HDPE (bottle) |
abacavir |
800 mg |
dispersable tablet |
Cipla |
India |
blister |
abacavir |
5% |
cream |
Cipla |
India |
Al tube |
abacavir |
200 mg |
tablet |
Ranbaxy |
India |
blister |
abacavir |
400 mg |
tablet |
Ranbaxy |
India |
blister |
aciclovir |
800 mg |
tablet |
Ranbaxy |
India |
blister |
amprenavir |
15 mg/ml |
oral solution |
GlaxoSmithKline |
UK |
HDPE (bottle) |
amprenavir |
50 mg
150 mg |
capsule |
GlaxoSmithKline |
France |
HDPE (bottle) |
ceftriazone |
500 mg |
inj. subst. |
Roche |
Switzerland |
glass vials |
ceftriazone |
250 mg |
Inj. subst. |
Roche |
Switzerland |
glass vials |
ciprofloxacin |
750 mg |
tablet |
Lab. Cinfa |
Spain |
blister |
ciprofloxacin |
500 mg |
tablet |
Lab.Cinfa |
Spain |
blister |
ciprofloxacin |
250 mg |
tablet |
Lab.Cinfa |
Spain |
blister |
ciprofloxacin |
100 mg |
tablet |
Cipla |
India |
blister |
ciprofloxacin |
250 mg |
tablet |
Cipla |
India |
blister |
ciprofloxacin |
500 mg |
tablet |
Cipla |
India |
blister |
ciprofloxacin |
750 mg |
tablet |
Cipla |
India |
blister |
ciprofloxacin |
250 mg |
tablet |
Ranbaxy |
India |
blister (PVC/Al) |
ciprofloxacin |
500 mg |
tablet |
Ranbaxy |
India |
blister (PVC/Al) |
ciprofloxacin |
750 mg |
tablet |
Ranbaxy |
India |
blister (PVC/Al) |
clarithromycin |
250 mg |
tablet |
Ranbaxy |
India |
blister (PVC/PVDC/Al) |
clarithromycin |
500 mg |
tablet |
Ranbaxy |
India |
blister (PVC/PVDC/Al) |
cotrimoxazole |
200 + 40 mg syrup |
|
Roche |
Switzerland |
amber glass bottle |
cotrimoxazole |
800 +160 mg tablet |
|
Roche |
Switzerland |
blister (PVC/Al) |
cotrimoxazole |
400 + 80 mg tablet |
|
Roche |
Switzerland |
blister |
didanosine |
25 mg |
tablet |
Bristol Myers Squibb |
France |
HDPE (bottle) |
didanosine |
50 mg |
tablet |
Bristol Myers Squibb |
France |
HDPE (bottle) |
didanosine |
100 mg |
tablet |
Bristol Myers Squibb |
France |
HDPE (bottle) |
didanosine |
150 mg |
tablet |
Bristol Myers Squibb |
France |
HDPE (bottle) |
didanosine |
200 mg |
chew. or dispersable tablet |
Bristol Myers Squibb |
France |
HDPE (bottle) |
fluconazole |
50 mg |
capsule |
Ranbaxy |
India |
blister |
fluconazole |
100 mg |
capsule |
Ranbaxy |
India |
blister |
fluconazole |
150 mg |
capsule |
Ranbaxy |
India |
blister |
fluconazole |
200 mg |
capsule |
Ranbaxy |
India |
blister |
ganciclovir |
500 mg |
Inj. Subst. |
Roche |
Switzerland |
glass vials |
indinavir |
400 mg |
capsule |
Hetero Drugs |
India |
strip (Al), HDPE bottle |
lamivudine |
150 mg |
tablet |
Hetero Drugs |
India |
strip (Al), HDPE bottle |
lamivudine |
150 mg |
tablet |
Ranbaxy |
India |
blister |
lamivudine |
150 mg |
tablet |
Cipla |
India |
blister |
lamivudine |
50 mg/5ml |
solution |
Cipla |
India |
PET (bottle) |
lamivudine |
150 mg |
tablet |
GlaxoSmithKline |
UK |
HDPE (bottle) |
lamivudine |
10 mg/ml |
oral solution |
GlaxoSmithKline |
UK |
HDPE (bottle) |
lamivudine+ zidovudine |
150/300 mg |
tablet |
Ranbaxy |
India |
blister |
lamivudine+ zidovudine |
150/300 mg |
tablet |
Cipla |
India |
blister |
lamivudine+ zidovudine |
150 mg +
300 mg |
tablet |
GlaxoSmithKline |
UK |
blister
HDPE (bottle) |
lamivudine+
zidovudine+
abacavir |
150 mg+
300 mg+
300 mg |
tablet |
GlaxoSmithKline |
UK |
blister
HDPE (bottle) |
nelfinavir |
250 mg |
film |
Roche |
Spain, |
plastic container |
mesylate |
|
coated tablet |
|
Switzerland |
|
nelfinavir |
0.50 mg |
oral |
Roche |
Switzerland |
HDPE (bottle) |
mesylate |
/ml |
suspension |
|
|
|
nevirapine |
200 mg |
tablet |
Ranbaxy |
India |
blister |
nevirapine |
200 mg |
tablet |
Cipla |
India |
blister |
nevirapine |
200 mg |
tablet |
Boehringer Ingelheim |
Germany |
blister |
nevirapine |
50 mg /5ml |
oral suspension |
Boehringer Ingelheim |
USA |
HDPE (bottle) + syringe |
nevirapine |
200 mg |
tablet |
Hetero Drugs |
India |
strip (Al)
HDPE (bottle) |
ritonavir |
100 mg |
capsule |
Abbott Laboratories |
USA
France |
HDPE (bottle) |
ritonavir |
80 mg/ml |
oral solution |
Abbott Laboratories |
UK |
PET (bottle) |
ritonavir+
lopinavir |
33,3 mg +
133,3 |
capsule |
Abbott Laboratories |
USA |
HDPE (bottle) |
ritonavir+
lopinavir |
20 mg +
80 mg/ml |
oral solution |
Abbott Laboratories |
UK |
PET (bottle) |
saquinavir |
200 mg |
soft capsule |
Roche |
Germany |
glass bottle |
saquinavir |
200 mg |
capsule |
Roche |
Switzerland |
glass bottle |
stavudine |
15 mg |
capsule |
Bristol Myers Squibb |
France |
blister
HDPE (bottle) |
stavudine |
20 mg |
capsule |
Bristol Myers Squibb |
France |
blister
HDPE (bottle) |
stavudine |
30 mg |
capsule |
Bristol Myers Squibb |
France |
blister
HDPE (bottle) |
stavudine |
40 mg |
capsule |
Bristol Myers Squibb |
France |
blister
HDPE (bottle) |
sulfadiazine |
500 mg |
tablet |
Doms Recordati |
France |
blister |
vinblastine sulfate |
10 mg /10 ml |
injection |
Cipla |
India |
vial |
vincristine sulfate |
1 mg/ml |
injection |
Cipla |
India |
vial |
zalcitabine |
0.375 mg |
tablet |
Roche |
USA
Switzerland |
blister (Al)
glass bottle |
zalcitabine |
0.75 mg |
tablet |
Roche |
USA |
blister (Al)
glass bottle |
zidovudine |
100 mg |
capsule |
Combino |
Spain |
strip (Al) |
zidovudine |
250 mg |
capsule |
Combino |
Spain |
blister PVC/AI |
zidovudine |
300 mg |
capsule |
Combino |
Spain |
blister PVC/AI |
zidovudine |
300 mg |
tablet |
Ranbaxy |
India |
blister |
zidovudine |
300 mg |
tablet |
Cipla |
India |
blister |
zidovudine |
100 mg |
capsule |
Cipla |
India |
HDPE (bottle) |
zidovudine |
50 mg/5ml |
solution |
Cipla |
India |
PET (bottle) |
zidovudine |
100 mg |
capsule |
GlaxoSmithKline |
UK |
blister
amber glass bottle |
zidovudine |
250 mg |
capsule |
GlaxoSmithKline |
UK |
blister |
zidovudine |
10 mg/ml |
infusion |
GlaxoSmithKline |
USA |
amber glass vial |
zidovudine |
50 mg/5 ml |
oral solution |
GlaxoSmithKline |
UK |
amber glass bottle |
zidovudine |
300 mg |
tablet |
GlaxoSmithKline |
UK |
blister (PVC/Al)
amber glass bottle |
zidovudine |
300 mg |
tablet |
Hetero Drugs |
India |
strip (Al)
HDPE bottle |
Al: |
aluminium |
HDPE: |
high density polyethylene |
PET: |
polyethylene terphthalate |
PVC: |
polyvinyl chloride |
PVDC: |
polyvinylidene chloride |
* More information on pre-qualification/assessment of manufacturing sites is available on the project website at http://www.who.int/medicines
List of generic antiretroviral products and manufacturers |
INN |
strength |
dosage form |
supplier |
country of origin |
indinavir |
400 mg |
capsule |
Hetero Drugs |
India |
lamivudine |
150 mg |
tablet |
Hetero Drugs |
India |
lamivudine |
150 mg |
tablet |
Ranbaxy |
India |
lamivudine |
150 mg |
tablet |
Cipla |
India |
lamivudine |
50 mg/5 ml |
solution |
Cipla |
India |
lamivudine + zidovudine |
150/300 mg |
tablet |
Ranbaxy |
India |
lamivudine + zidovudine |
150/300 mg |
tablet |
Cipla |
India |
nevirapine |
200 mg |
tablet |
Ranbaxy |
India |
nevirapine |
200 mg |
tablet |
Cipla |
India |
nevirapine |
200 mg |
tablet |
Hetero Drugs |
India |
zidovudine |
100 mg |
capsule |
Combino |
Spain |
zidovudine |
250 mg |
capsule |
Combino |
Spain |
zidovudine |
300 mg |
capsule |
Combino |
Spain |
zidovudine |
300 mg |
tablet |
Ranbaxy |
India |
zidovudine |
300 mg |
tablet |
Cipla |
India |
zidovudine |
100 mg |
capsule |
Cipla |
India |
zidovudine |
50 mg/5 ml |
solution |
Cipla |
India |
zidovudine |
300 mg |
tablet |
Hetero Drugs |
India |
Cargando...
